ADIPOQ and kidney cancer: In this work, (1) we evaluate the correlation between adiponectin and leptin expression with clinical and pathological characteristics of kidney cancer patients, and (2) we evaluated whether differential expression of hAT-secreted proteins was sufficient to separate healthy patients from patients with kidney cancer, using unsupervised machine learning algorithms.